MIS-C Treatment: Is IVIG Always Necessary?

• প্রধান লেখক: Francesco Licciardi (লেখক), Letizia Baldini (লেখক), Marta Dellepiane (লেখক), Carlotta Covizzi (লেখক), Roberta Mogni (লেখক), Giulia Pruccoli (লেখক), Cecilia Orsi (লেখক), Ivana Rabbone (লেখক), Emilia Parodi (লেখক), Federica Mignone (লেখক), Davide Montin (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: MIS-C is a potentially severe inflammatory syndrome associated with SARS-CoV-2 exposure. Intravenous immunoglobulin (IVIG) is considered the first-tier therapy, but it implies infusion of large fluid volumes that may worsen cardiac function.Patients and Methods: Since April 2020, we have...